Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine versus sublingual misoprostol for prevention of postpartum hemorrhage at elective caesarean section
PACTR202309644870215Phase 2Completed
- Sponsor
- Self sponsored DR CHIDINMA PEACE OHACHENU
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Self sponsored DR CHIDINMA PEACE OHACHENU. Primary endpoints: Overall blood loss and Intraoperative blood loss. Started Oct 2023; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202309644870215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202309644870215.